Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, UK.
Specialist Trainee in Palliative Medicine, Pembridge Palliative Care Unit, London, UK.
Thorax. 2018 Sep;73(9):880-883. doi: 10.1136/thoraxjnl-2017-210911. Epub 2017 Nov 17.
The inter-rater/test-retest reliability and construct validity of a palliative care needs assessment tool in interstitial lung disease (NAT:PD-ILD) were tested using NAT:PD-ILD-guided video-recorded consultations, and NAT:PD-ILD-guided consultations, and patient and carer-report outcomes (St George's Respiratory Questionnaire (SGRQ)-ILD, Carer Strain Index (CSI)/Carer Support Needs Assessment Tool (CSNAT)). 11/16 items reached at least fair inter-rater agreement; 5 items reached at least moderate test-retest agreement. 4/6 patient constructs demonstrated agreement with SGRQ-I scores (Kendall's tau-b, 0.24-20.36; P<0.05). 4/7 carer constructs agreed with the CSI/CSNAT items (kappa, 0.23-20.53). The NAT:PD-ILD is reliable and valid. Clinical effectiveness and implementation are to be evaluated.
使用 NAT:PD-ILD 指导的视频记录咨询和 NAT:PD-ILD 指导的咨询以及患者和护理人员报告的结果(圣乔治呼吸问卷 (SGRQ)-ILD、护理人员压力指数 (CSI)/护理人员支持需求评估工具 (CSNAT)),测试了间质性肺病 (NAT:PD-ILD) 姑息治疗需求评估工具的评分者间/重测信度和结构效度。11/16 项达到了至少是中等的评分者间一致性;5 项达到了至少是中等的重测信度。4/6 项患者结构与 SGRQ-I 评分一致(肯德尔 tau-b,0.24-20.36;P<0.05)。4/7 项护理人员结构与 CSI/CSNAT 项目一致(kappa,0.23-20.53)。NAT:PD-ILD 是可靠和有效的。将评估其临床效果和实施情况。